# SOTYKTU

NDC: 0003-0895
Generic name: deucravacitinib
Labeler / Manufacturer: E.R. Squibb & Sons, L.L.C.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20220909

FDA application: NDA214958

## Active ingredients

- DEUCRAVACITINIB: 6 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0003-0895"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0003-0895
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ff4d7258-5068-4cdf-9692-8cae04c3198e